Document and Entity Information
Document and Entity Information | Jan. 10, 2022 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | On January 10, 2022, EyePoint Pharmaceuticals, Inc. (the “Company”) filed a Current Report on Form 8-K to report that the Company posted an updated corporate presentation on its website at www.eyepointpharma.com. This Amendment No. 1 to Current Report on Form 8-K/A (“Amendment No. 1”) is being filed to report that the Company has posted a further updated corporate presentation on its website at www.eyepointpharma.com to correct certain scrivener’s errors contained in the previous version of the corporate presentation. A copy of the corrected presentation is filed herewith as Exhibit 99.1 and is incorporated by reference herein. |
Document Period End Date | Jan. 10, 2022 |
Entity Registrant Name | EyePoint Pharmaceuticals, Inc. |
Entity Central Index Key | 0001314102 |
Trading Symbol | EYPT |
Entity Emerging Growth Company | false |
Entity File Number | 000-51122 |
Entity Tax Identification Number | 26-2774444 |
Entity Address, Address Line One | 480 Pleasant Street |
Entity Address, City or Town | Watertown |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02472 |
City Area Code | (617) |
Local Phone Number | 926-5000 |
Entity Incorporation, State or Country Code | DE |
Title of 12(b) Security | Common Stock, par value $0.001 |
Security Exchange Name | NASDAQ |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |